Interleukin-10 induces interferon-γ-dependent emergency myelopoiesis

Cell Rep. 2021 Oct 26;37(4):109887. doi: 10.1016/j.celrep.2021.109887.

Abstract

In emergency myelopoiesis (EM), expansion of the myeloid progenitor compartment and increased myeloid cell production are observed and often mediated by the pro-inflammatory cytokine interferon gamma (IFN-γ). Interleukin-10 (IL-10) inhibits IFN-γ secretion, but paradoxically, its therapeutic administration to humans causes hematologic changes similar to those observed in EM. In this work, we use different in vivo systems, including a humanized immune system mouse model, to show that IL-10 triggers EM, with a significant expansion of the myeloid progenitor compartment and production of myeloid cells. Hematopoietic progenitors display a prominent IFN-γ transcriptional signature, and we show that IFN-γ mediates IL-10-driven EM. We also find that IL-10, unexpectedly, reprograms CD4 and CD8 T cells toward an activation state that includes IFN-γ production by these T cell subsets in vivo. Therefore, in addition to its established anti-inflammatory properties, IL-10 can induce IFN-γ production and EM, opening additional perspectives for the design of IL-10-based immunotherapies.

Keywords: IFN-γ; IL-10; T cells; emergency myelopoiesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Interferon-gamma / genetics
  • Interferon-gamma / immunology*
  • Interleukin-10 / genetics
  • Interleukin-10 / immunology*
  • Mice
  • Mice, Knockout
  • Myeloid Progenitor Cells / immunology*
  • Myelopoiesis / genetics
  • Myelopoiesis / immunology*

Substances

  • IFNG protein, mouse
  • IL10 protein, mouse
  • Interleukin-10
  • Interferon-gamma